Blog
Get the latest news about liver diseases and more
Get the latest news about liver diseases and more
New trials published with hepatitis B patients suggests the use of liposome nanoparticles with virus antigens for their treatment.
We analyze the latest studies carried out regarding post-vacial protection against coronavirus and the appearance of new medications.
Two recent studies carried out with antiviral drugs demonstrate their effectiveness against Coronavirus.
We analyze the need for a third dose of reinforcement against coronavirus and studies published in this regard.
Last studies give light on the duration of the vaccine and the need for reinforcement against the COVID-19.
At the European Congress on Liver Diseases, held at the end of June, an interesting work was presented in relation to fatty liver.
Although numerous studies have been published on COVID-19, works regarding the durability of post-vaccination protection are scarce.
In addition to vaccines there are other methods to reduce the possibility of coronavirus infection.
23 de August de 2018
11 de February de 2021
29 de July de 2022